My favorite travel card offers over $800 in first-year value, all from its welcome bonus and one simple perk. Here's how to ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) ...

EdgeMode (OTC: EDGM), a global Energy and AI data center infrastructure company, in a joint venture with Blackberry Alternative Investment Fund (BAIF), has announced a major operational milestone in ...

Milestone Pharmaceuticals ( (MIST)) has shared an announcement. On December 12, 2025, Milestone Pharmaceuticals announced that the U.S. Food and Drug Administration approved their New Drug Application ...

• Milestone Pharmaceuticals Inc. (MIST) shares surged 39% to $3.35 in pre-market trading following FDA approval of CARDAMYST™. • CARDAMYST™ is the first self-administered nasal spray for Paroxysmal ...

First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythm FDA approval in PSVT ...

Gemini Space Station, Inc. (NASDAQ:GEMI) announced a major regulatory victory on Wednesday, December 10, 2025, confirming that its affiliate, Gemini Titan, LLC (Titan), has received a Designated ...

Foundation Medicine, Inc., a precision medicine company transforming lives in cancer and beyond, today announced it has achieved a historic, unprecedented milestone of 100 approved companion ...

Tesla may have celebrated a regulatory win in Europe a bit too soon. Tesla claimed in a weekend social media post that Dutch regulator RDW was set to approve the use of its driver assistance system, ...

The inevitable is finally here and Dak Prescott is here for it. As the Dallas Cowboys head into another heavyweight showdown with the Philadelphia Eagles, Dak Prescott enters the game needing only 160 ...

President Donald Trump’s approval rating has hit its lowest of his second term as Americans’ disapproval grows of his handling of the Jeffrey Epstein case and the cost of living, according to a new ...

XRP (CRYPTO: XRP) is gaining real traction with institutions in late 2025. We’re seeing a genuine shift here — from retail-driven hype to actual enterprise adoption. Ripple’s been busy: acquisitions, ...